IUHSA
RNAM

Itau Unibanco Holding S.A.’s Avidity Biosciences RNAM Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-426
Closed -$17.4K – 412
2024
Q2 		$17.4K Buy
+426
New +$12.2K ﹤0.01% 231
2024
Q1 		– Sell
-2,958
Closed -$26.8K – 311
2023
Q4 		$26.8K Buy
2,958
+644
+28% +$4.3K ﹤0.01% 253
2023
Q3 		$14.8K Buy
2,314
+569
+33% +$4.9K ﹤0.01% 394
2023
Q2 		$19.4K Sell
1,745
-159
-8% -$1.99K ﹤0.01% 422
2023
Q1 		$29.2K Sell
1,904
-6
-0.3% -$132 ﹤0.01% 371
2022
Q4 		$42.4K Buy
1,910
+298
+18% +$4.44K ﹤0.01% 351
2022
Q3 		$26K Buy
+1,612
New +$30.8K ﹤0.01% 424

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Itau Unibanco Holding S.A.'s RNAM Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of Avidity Biosciences (RNAM) in Q3 2024, closing a stake of 426 shares — an estimated $17.4K sold.

Itau Unibanco Holding S.A. first reported a position in RNAM in Q3 2022 and held it in 7 quarters. The position peaked at $42.4K in Q4 2022. 245 funds tracked by Wall St. Rank hold RNAM as of Q3 2024.

  • Itau Unibanco Holding S.A. reported no remaining Avidity Biosciences position as of Q3 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 426 Avidity Biosciences shares in Q3 2024, an estimated $17.4K.
  • Itau Unibanco Holding S.A. first reported a position in Avidity Biosciences in Q3 2022 and held it in 7 quarters.
  • Itau Unibanco Holding S.A.'s Avidity Biosciences position peaked at $42.4K in Q4 2022.
  • 245 funds tracked by Wall St. Rank held Avidity Biosciences as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.